IGC Pharma Inc
IGC
Get informed when a big investor buys or sells
+ FollowMarket Cap$28.02M
Close$
$-0.11
143.7% downside
Current Fair Value
143.7% downsideOvervalued by 143.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $28.02 Million |
|---|---|
| Enterprise Value | $27.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 0.48 |
| Outstanding Shares | 100,331,320 |
Return
| Return on Equity | -128.59% |
|---|---|
| Return on Assets | -83.03% |
| Return on Invested Capital | -159.27% |
Valuation & Multiples
| P/E Ratio | -3.4 |
|---|---|
| PEG | -4.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 24.65 |
| Enterprise Value to EBIT | -2.77 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$164,000
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$164,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 14,600▲ Infinity% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.18%▲ 0.62% |
|---|---|
| Total Invested | $1.41M▲ 24.02% |
| Investors Holding | 37▲ 2.00% |
ESG Score
No data
About India Globalization Capital Inc
CEO: Ram Mukunda